Jump To
Jump To
While advancements in artificial intelligence (AI) are attracting attention across the entire innovation economy, few sectors stand to benefit more than healthcare. Over the last five years, AI deal activity has grown faster in healthcare than in tech overall, as investors and innovators recognize AI's potential to improve administrative efficiency, patient diagnostics, drug discovery and more. Our inaugural report on AI-powered healthcare focuses on emerging AI applications in healthcare, particularly the administrative and clinical use cases that account for the majority of current venture capital investment.
Diagnostic companies focused on imaging have seen the greatest investment growth since 2021.
2024 is on track to reach $11.1B.
AI's proportion of total US VC healthcare investment is the highest it's ever been.
Our first-ever report on healthcare AI uses SVB proprietary data and market analysis to map the AI's evolving impact on the patient journey and experience.
Since 2019, the number of AI deals in healthcare has grown at twice the rate of AI deals across the entire tech sector.
Investments have largely focused on AI that improves workflows for doctors by automating administrative tasks like scheduling and billing. Investors and buyers are critically evaluating new AI solutions by how readily they'll be adopted and how much business value they can offer.
Explore our full report for insight into the use of AI to improve the patient journey.
Reports
Apr 15, 2026
Jordan Kanis, Eli Oftedal, Josh Pherigo, Andrew Pardo
Reports
Jordan Kanis, Joshua Posamentier, Eliza Cushman, Marianne Wu, Hilla Watkins
Reports
Mark Gallagher, Patrick Eggen, Mikey Kalis, Emma Eschweiler, Abbie Wolf, Anjalika Komatireddy, Eli Oftedal, Jake Ledbetter